ZNF800

Across TCGA pan-cancer cohorts, ZNF800 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of ZNF800’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where ZNF800 RNA is repressed in tumor relative to normal tissue. In most cancer types ZNF800 is over-expressed in tumor, although a few such as THCA and UCEC show the opposite, repressed pattern.

THCA, KIRP, and COAD are the cancer types where ZNF800 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF800 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.586	<.001	9	view →
KIRP	All	All	+0.392	.004	7	view →
COAD	Male	All	+0.491	.001	4	view →
KIRC	All	All	+0.328	<.001	4	view →
CHOL	Male	All	+1.111	<.001	2	view →
ESCA	Female	All	+0.900	.011	2	view →
UCEC	All	All	−0.452	.003	2	view →
LUAD	All	IV	+0.315	.034	2	view →
LUSC	Female	II,III,IV	−0.652	.036	1	view →
KICH	Female	All	−0.454	.040	1	view →
LUAD	Female	II,III,IV	−0.274	.023	1	view →
LIHC	All	All	+0.226	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 11 lineages.

ZNF800–THCA

Open the THCA breakdown →